These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 22234378)

  • 1. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters.
    Davey KJ; O'Mahony SM; Schellekens H; O'Sullivan O; Bienenstock J; Cotter PD; Dinan TG; Cryan JF
    Psychopharmacology (Berl); 2012 May; 221(1):155-69. PubMed ID: 22234378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat.
    Davey KJ; Cotter PD; O'Sullivan O; Crispie F; Dinan TG; Cryan JF; O'Mahony SM
    Transl Psychiatry; 2013 Oct; 3(10):e309. PubMed ID: 24084940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
    Fell MJ; Anjum N; Dickinson K; Marshall KM; Peltola LM; Vickers S; Cheetham S; Neill JC
    Psychopharmacology (Berl); 2007 Oct; 194(2):221-31. PubMed ID: 17581744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body weight and plasma levels of ghrelin and leptin during treatment with olanzapine.
    Kim BJ; Sohn JW; Park CS; Hahn GH; Koo J; Noh YD; Lee CS
    J Korean Med Sci; 2008 Aug; 23(4):685-90. PubMed ID: 18756058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of olanzapine-induced weight gain by the retinoid analog AM-80.
    Richards M; Chiba S; Ninomiya M; Wakabayasi C; Kunugi H
    Pharmacopsychiatry; 2013 Nov; 46(7):267-73. PubMed ID: 24105080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats.
    Horska K; Ruda-Kucerova J; Babinska Z; Karpisek M; Demlova R; Opatrilova R; Suchy P; Kotolova H
    Psychoneuroendocrinology; 2016 Nov; 73():177-185. PubMed ID: 27504985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
    Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
    Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine-induced accumulation of adipose tissue is associated with an inflammatory state.
    Victoriano M; de Beaurepaire R; Naour N; Guerre-Millo M; Quignard-Boulangé A; Huneau JF; Mathé V; Tomé D; Hermier D
    Brain Res; 2010 Sep; 1350():167-75. PubMed ID: 20570665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways.
    Liu X; Lian J; Hu CH; Deng C
    Pharmacol Res; 2015 Oct; 100():36-46. PubMed ID: 26218603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.
    Girault EM; Guigas B; Alkemade A; Foppen E; Ackermans MT; la Fleur SE; Fliers E; Kalsbeek A
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Feb; 387(2):185-95. PubMed ID: 24190543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model.
    Horska K; Kucera J; Drazanova E; Kuzminova G; Amchova P; Hrickova M; Ruda-Kucerova J; Skrede S
    Biomed Pharmacother; 2024 Jul; 176():116763. PubMed ID: 38805968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats.
    Skrede S; González-García I; Martins L; Berge RK; Nogueiras R; Tena-Sempere M; Mellgren G; Steen VM; López M; Fernø J
    Int J Neuropsychopharmacol; 2017 Dec; 20(12):1005-1012. PubMed ID: 29020342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of olanzapine on the elevation of macrophage infiltration and pro-inflammatory cytokine expression in female rats.
    Zhang Q; He M; Deng C; Wang H; Huang XF
    J Psychopharmacol; 2014 Dec; 28(12):1161-9. PubMed ID: 25336715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain.
    Patil BM; Kulkarni NM; Unger BS
    Eur J Pharmacol; 2006 Dec; 551(1-3):112-5. PubMed ID: 17046744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats.
    Lazzari P; Serra V; Marcello S; Pira M; Mastinu A
    Eur Neuropsychopharmacol; 2017 Jul; 27(7):667-678. PubMed ID: 28377074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
    Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
    Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
    Cooper GD; Harrold JA; Halford JC; Goudie AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic antipsychotic drug exposure on the expression of Translocator Protein and inflammatory markers in rat adipose tissue.
    Calevro A; Cotel MC; Natesan S; Modo M; Vernon AC; Mondelli V
    Psychoneuroendocrinology; 2018 Sep; 95():28-33. PubMed ID: 29793094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.
    Weston-Green K; Huang XF; Deng C
    PLoS One; 2012; 7(3):e33548. PubMed ID: 22438946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with olanzapine via a novel infusion pump induces adiposity in male rats.
    Shobo M; Yamada H; Koakutsu A; Hamada N; Fujii M; Harada K; Ni K; Matsuoka N
    Life Sci; 2011 Apr; 88(17-18):761-5. PubMed ID: 21356217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.